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Off-pump coronary bypass surgery,
graft patency, and the need of an
informed consent
To the Editor:
We read with interest the article by Lim
and colleagues1 concerning graft patency
after off-pump coronary bypass surgery
(OPCAB). They showed that both patency
and number of distal anastomoses are
lower in OPCAB, which confirms and ex-
tends previous evidence published by our
group concerning reduced patency rates.2-4
The OPCAB technique was developed
and reintroduced in the clinical practice for
economic reasons in some southern America
countries more than a decade ago, and
then it became progressively adopted by
European and North America centers to
reduce trauma, thus rendering coronary by-
pass surgery an easier choice compared
with less invasive options (eg, interven-
tional cardiologic procedures).
In recent years, evidence has accumu-
lated concerning both the pros and cons of
the OPCAB approach. It is now well estab-
lished that OPCAB is associated with a
reduced rate of minor outcomes such as the
incidence of postoperative atrial fibrilla-
tion, the need of blood products, and prob-
ably reduced myocardial enzyme release.4
On the other hand, the risk of reduced
patency and reduced revascularization is an
important issue of OPCAB procedures.
Thus, patients should be extensively in-
formed about the pros and cons of the
OPCAB approach before surgery, and they
should clearly express their acceptance to
undergo OPCAB.
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